Washington’s life science industry continues to make headlines, cement its status as a top national cluster, and outperform other sectors during the economic slowdown.
With Pfizer’s announcement to acquire Seagen (our state’s largest biotech company), Washington is now home to the largest biotech deal since 2019. The work of Seagen and other local companies in developing some of the most innovative, impactful, and sought-after cancer therapies in the world has made Washington a top 10 life science cluster in the country. Pfizer has indicated they intend to maintain and continue to invest in Seagen’s extensive Bothell and Everett operations. At the other end of the economic spectrum, a local father is stepping in to lead a UW spinout to cure his son’s Duchenne muscular dystrophy.
Read about these stories and more in our new quarterly newsletter highlighting the most exciting life science news from across the state.
Click here to view original post